Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4I89

Crystal structure of transthyretin in complex with diflunisal at acidic pH

Summary for 4I89
Entry DOI10.2210/pdb4i89/pdb
Related4I85 4I87
DescriptorTransthyretin, 5-(2,4-DIFLUOROPHENYL)-2-HYDROXY-BENZOIC ACID (3 entities in total)
Functional Keywordsamyloidosis, fibrillogenesis inhibitor, transthyretin stabilizers, t4 or t3 hormone, plasma, transport protein-inhibitor complex, transport protein/inhibitor
Biological sourceHomo sapiens (human)
Cellular locationSecreted: P02766
Total number of polymer chains2
Total formula weight28002.96
Authors
Zanotti, G.,Cendron, L.,Folli, C.,Florio, P.,Imbimbo, B.P.,Berni, R. (deposition date: 2012-12-03, release date: 2013-06-19, Last modification date: 2023-09-20)
Primary citationZanotti, G.,Cendron, L.,Folli, C.,Florio, P.,Imbimbo, B.P.,Berni, R.
Structural evidence for native state stabilization of a conformationally labile amyloidogenic transthyretin variant by fibrillogenesis inhibitors.
Febs Lett., 587:2325-2331, 2013
Cited by
PubMed: 23792159
DOI: 10.1016/j.febslet.2013.06.016
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.69 Å)
Structure validation

217705

PDB entries from 2024-03-27

PDB statisticsPDBj update infoContact PDBjnumon